Here's the Simple Reason Why Multiple Sclerosis Drugs Cost So Much
Two members of the U.S. House of Representatives Committee on Oversight and Government Reform want to know why the prices of multiple sclerosis (MS) drugs are so high. Rep. Elijah Cummings (D-Md.) and Rep. Peter Welch (D-Vt.) have sent letters to seven drugmakers, including Biogen (NASDAQ: BIIB) and Teva Pharmaceutical Industries (NYSE: TEVA), asking for information about factors related to pricing for their MS products.
These letters appear to be an opening salvo in what Cummings and Welch vow will be a full investigation into pricing of MS drugs. I don't think an investigation is needed at all, though. There's a simple reason why these drugs cost so much: It's just the way our system works.
Source: Fool.com
Teva Pharmaceutical Industries Ltd ADR Stock
Teva Pharmaceutical Industries Ltd ADR is currently one of the favorites of our community with 11 Buy predictions and no Sell predictions.
As a result the target price of 13 € shows a slightly positive potential of 1.56% compared to the current price of 12.8 € for Teva Pharmaceutical Industries Ltd ADR.